Skip to main content
Erschienen in: Journal of Cancer Education 3/2012

01.06.2012

Radon Testing and Mitigation: An Intervention in a Primary Care Setting

verfasst von: Mary Jo Nissen, Joseph W. Leach, Julia A. Nissen, Karen K. Swenson, Heather Kehn

Erschienen in: Journal of Cancer Education | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Radon is the second leading cause of lung cancer and it is recommended that all homes be tested for radon. Written surveys completed by 692 patients at two primary care clinics in the Minneapolis, MN, area revealed that only 24.7 % had ever tested their home. Testing rate was higher with greater income and education level and in homes without someone who smokes. Of participants whose homes had not been tested, 250 were enrolled in an intervention that included printed information on radon, a coupon for a discounted testing kit, and encouragement by their primary care provider to test. Follow-up indicated minimal effect of this intervention, with only 14.4 % of these participants testing during the ensuing year. Future studies should assess a stronger intervention, perhaps over multiple visits, and providing test kits on site. Targeting patients who smoke may be an effective use of resources.
Literatur
1.
Zurück zum Zitat Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics 2010. CA Cancer J Clin 60(5):277–300PubMedCrossRef Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics 2010. CA Cancer J Clin 60(5):277–300PubMedCrossRef
2.
Zurück zum Zitat National Research Council. Committee on the Biological Effects of Ionizing Radiation (1999) Health effects of exposure to low levels of radon (BIER VI). Washington: National Academy Press National Research Council. Committee on the Biological Effects of Ionizing Radiation (1999) Health effects of exposure to low levels of radon (BIER VI). Washington: National Academy Press
3.
Zurück zum Zitat Field RW, Krewski D, Lubin JH, Zielinski JM, Alavanja M, Catalan VS et al (2006) An overview of the North American residential radon and lung cancer case–control studies. J Toxicol Env Health A 69(7):599–631CrossRef Field RW, Krewski D, Lubin JH, Zielinski JM, Alavanja M, Catalan VS et al (2006) An overview of the North American residential radon and lung cancer case–control studies. J Toxicol Env Health A 69(7):599–631CrossRef
4.
Zurück zum Zitat Krewski D, Lubin JH, Zielinski JM, Alavanja M, Catalan V, Field RW et al (2006) A combined analysis of North American case–control studies of residential radon and lung cancer. J Toxicol Env Health A 69(7):533–597CrossRef Krewski D, Lubin JH, Zielinski JM, Alavanja M, Catalan V, Field RW et al (2006) A combined analysis of North American case–control studies of residential radon and lung cancer. J Toxicol Env Health A 69(7):533–597CrossRef
6.
Zurück zum Zitat Reif AE, Heeren T (1999) Consensus on synergism between cigarette smoke and other environmental carcinogens in the causation of lung cancer. Adv Cancer Res 76:161–186PubMedCrossRef Reif AE, Heeren T (1999) Consensus on synergism between cigarette smoke and other environmental carcinogens in the causation of lung cancer. Adv Cancer Res 76:161–186PubMedCrossRef
8.
Zurück zum Zitat Eheman CR, Ford E, Garbe P (1996) Knowledge about indoor radon in the United States:1990 National Health Interview Survey. Arch Environ Health 51(3):245–247PubMedCrossRef Eheman CR, Ford E, Garbe P (1996) Knowledge about indoor radon in the United States:1990 National Health Interview Survey. Arch Environ Health 51(3):245–247PubMedCrossRef
10.
Zurück zum Zitat Larsson LS, Hill WG, Odom-Maryon T, Yu P (2009) Householder status and residence type as correlates of radon awareness and testing behaviors. Public Health Nurs 26(5):387–395PubMedCrossRef Larsson LS, Hill WG, Odom-Maryon T, Yu P (2009) Householder status and residence type as correlates of radon awareness and testing behaviors. Public Health Nurs 26(5):387–395PubMedCrossRef
11.
Zurück zum Zitat Riesenfeld EP, Marcy TW, Reinier K, Mongeon JA, Trumbo CW, Wemple BE, Kaminsky DA (2007) Radon awareness and mitigation in Vermont: a public health survey. Health Phys 92(5):425–431PubMedCrossRef Riesenfeld EP, Marcy TW, Reinier K, Mongeon JA, Trumbo CW, Wemple BE, Kaminsky DA (2007) Radon awareness and mitigation in Vermont: a public health survey. Health Phys 92(5):425–431PubMedCrossRef
12.
Zurück zum Zitat Wang Y, Ju C, Stark AD, Teresi N (1999) Radon mitigation survey among New York state residents living in high radon homes. Health Phys 7(4):403–409CrossRef Wang Y, Ju C, Stark AD, Teresi N (1999) Radon mitigation survey among New York state residents living in high radon homes. Health Phys 7(4):403–409CrossRef
13.
Zurück zum Zitat Viera AJ (2000) Radon and lung cancer. Am Fam Physician 62(5):950–951PubMed Viera AJ (2000) Radon and lung cancer. Am Fam Physician 62(5):950–951PubMed
14.
Zurück zum Zitat Wang Y, Ju C, Stark AD, Teresi N (2000) Radon awareness, testing, and remediation survey among New York state residents. Health Phys 78(6):641–647PubMedCrossRef Wang Y, Ju C, Stark AD, Teresi N (2000) Radon awareness, testing, and remediation survey among New York state residents. Health Phys 78(6):641–647PubMedCrossRef
17.
Zurück zum Zitat Halpern MT, Warner KE (1994) Radon risk perception and testing: sociodemographic correlates. J Environ Health 56(7):31–35 Halpern MT, Warner KE (1994) Radon risk perception and testing: sociodemographic correlates. J Environ Health 56(7):31–35
18.
Zurück zum Zitat Ford ES, Eheman CR, Siegel PZ, Garbe PL (1996) Radon awareness and testing behavior: findings from the Behavioral Risk Factor Surveillance System, 1989–1992. Health Phys 70(3):363–366PubMedCrossRef Ford ES, Eheman CR, Siegel PZ, Garbe PL (1996) Radon awareness and testing behavior: findings from the Behavioral Risk Factor Surveillance System, 1989–1992. Health Phys 70(3):363–366PubMedCrossRef
19.
Zurück zum Zitat Kaner EFS, Dickinson HO, Beyer FR, Campbell F, Schlesinger C, Heather N, Saunders JB, Burnand B, Pienaar ED (2007) Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD004148. doi:10.1002/14651858.CD004148.pub3 Kaner EFS, Dickinson HO, Beyer FR, Campbell F, Schlesinger C, Heather N, Saunders JB, Burnand B, Pienaar ED (2007) Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD004148. doi:10.​1002/​14651858.​CD004148.​pub3
21.
Zurück zum Zitat Goldstein MG, Whitlock EP, DePue J, Planning Committee of the Addressing Multiple Behavioral Risk Factors in Primary Care Project (2004) Multiple behavioral risk factor interventions in primary care: summary of research evidence. Am J Prev Med 27(2):61–79PubMedCrossRef Goldstein MG, Whitlock EP, DePue J, Planning Committee of the Addressing Multiple Behavioral Risk Factors in Primary Care Project (2004) Multiple behavioral risk factor interventions in primary care: summary of research evidence. Am J Prev Med 27(2):61–79PubMedCrossRef
Metadaten
Titel
Radon Testing and Mitigation: An Intervention in a Primary Care Setting
verfasst von
Mary Jo Nissen
Joseph W. Leach
Julia A. Nissen
Karen K. Swenson
Heather Kehn
Publikationsdatum
01.06.2012
Verlag
Springer-Verlag
Erschienen in
Journal of Cancer Education / Ausgabe 3/2012
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-012-0346-z

Weitere Artikel der Ausgabe 3/2012

Journal of Cancer Education 3/2012 Zur Ausgabe

Nodal-negativ nach neoadjuvanter Chemo: Axilladissektion verzichtbar?

03.05.2024 Mammakarzinom Nachrichten

Wenn bei Mammakarzinomen durch eine neoadjuvante Chemotherapie ein Downstaging von nodal-positiv zu nodal-negativ gelingt, scheint es auch ohne Axilladissektion nur selten zu axillären Rezidiven zu kommen.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Bestrahlung nach Prostatektomie: mehr Schaden als Nutzen?

02.05.2024 Prostatakarzinom Nachrichten

Eine adjuvante Radiotherapie nach radikaler Prostata-Op. bringt den Betroffenen wahrscheinlich keinen Vorteil. Im Gegenteil: Durch die Bestrahlung steigt offenbar das Risiko für Harn- und Stuhlinkontinenz.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.